Integral Systems, Inc. (Integral) (NASDAQ:ISYS) announced today that it has purchased the intellectual property and other assets relating to the satID product line from U.K.-based QinetiQ Group PLC.
NIH Funds Discovery Of New Influenza Inhibitors By Integral Molecular, Inc. Integral Molecular, Inc. initiates a federally-funded program to discover new drugs to combat influenza infection. Sponsored ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback